Paroxetine Treatment of Depression with Posttraumatic Stress Disorder: Effects on Autonomic Reactivity and Cortisol Secretion

Journal of Clinical Psychopharmacology

Volumn 24, Issue 2, 2004, Pages 131-140

  Tucker, Phebe ^a   Beebe, Katherine L ^b   Burgin, Christie ^c   Wyatt, Dorothy B ^a   Parker, Don E ^c   Masters, Barbara K ^a,c   Nawar, Ola ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HEART RATE; HUMAN; HYDROCORTISONE RELEASE; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; SIDE EFFECT;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; AUTONOMIC NERVOUS SYSTEM; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 1642271370     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000116649.91923.cb     Document Type: Article

References (41)

1. Kessler RC, Sonnega A, Bromet E, et al. Post-traumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048-1060.
2. Pitman RK, Orr SP, Forgue DF, et al. Psychophysiological assessment of posttraumatic stress disorder imagery in Vietnam combat veterans. Arch Gen Psychiatry. 1987;44:970-975.
3. Pitman RK, Orr SP, Steketee GS. Psychophysiological investigations of posttraumatic stress disorder imagery. Psychopharmacol Bull. 1989;25:426-431.
4. Orr SP, Claiborn JM, Altman B, et al. Psychometric profile of posttraumatic stress disorder, anxious and healthy Vietnam veterans: correlations with psychophysiological responses. J Consult Clin Psychol. 1990;58:329-335.
5. McFall ME, Murburg MM, Ko GN, et al. Autonomic responses to stress in Vietnam combat veterans with posttraumatic stress disorder. Biol Psychiatry. 1990;27:1165-1175.
6. Shalev AY, Orr SP, Pitman RK. Psychophysiologic assessment of traumatic imagery in Israeli civilian patients with posttraumatic stress disorder. Am J Psychiatry. 1993;150:620-624.
7. Blanchard EB, Hickling EJ, Taylor AE. The psychophysiology of motor vehicle accident related posttraumatic stress disorder. Biofeedback Self-Regul. 1991;16:449-458.
8. Tucker P, Smith KL, Marx B, et al. Fluvoxamine reduces physiologic reactivity to trauma scripts in posttraumatic stress disorder. J Clin Psychopharmacol. 2000;20(3):367-372.
9. Yehuda R. Biology of posttraumatic stress disorder [review]. J Clin Psychiatry. 2000;61(suppl 7):14-21.
10. Goenjian AK, Yehuda R, Pynoos RS, et al. Basal cortisol, dexamethasone suppression of cortisol and MHPG in adolescents after the 1988 earthquake in Armenia. Am J Psychiatry. 1996;153(7):929-934.
11. Lemieux AM, Coe CL. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Am Psychosom Soc. 1995;57(2):105-115.
12. Liberzon I, Abelson JL, Flagel SB, et al. Neuroendocrine and psychophysiologic responses in PTSD: a symptom provocation study. Neuropsychopharmacology. 1999;21(1):40-50.
13. Fukuda S, Morimoto K, Mure K, et al. Effect of the Hanshin-Awaji earthquake on posttraumatic stress, lifestyle changes, and cortisol levels of victims. Arch Environ Health. 2000;55(2):121-125.
14. Rasmusson AM, Lipschitz DS, Wang S, et al. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry. 2001;50(12):965-977.
15. Stein MB, Yehuda R, Koverola C, et al. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry. 1997;42(8):680-686.
16. Yehuda R, Halligan SL, Bierer LM. Cortisol levels in adult offspring of Holocaust survivors: relation to PTSD symptom severity in the parent and child. Psychoneuroendocrinology. 2002;27(1-2):171-180.
17. Holsboer F. Neuroendocrinology of mood disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:954-970.
18. Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment of chronic PTSD: a fixed dosage placebo-controlled study. Am J Psychiatry. 2001;158:1982-1988.
19. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic PTSD: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62(11):860-869.
20. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837-1844.
21. Davidson JRT, Rothbaum BO, van der Kolk BA, et al. Multi-center, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
22. Davidson JR, Kudler H, Smith R, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47:259-266.
23. Kosten TR, Frank JB, Dan E. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179:366-370.
24. Fichtner CG, Arora RC, O'Connor FL, et al. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress: preliminary observations on a possible predictor of clinical treatment response. Life Sci. 1994;54:PL39-PL44.
25. Cohen H, Kotler M, Matar M, et al. Normalization of heart rate variability in posttraumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr Med Assoc J. 2000;2(4): 296-301.
26. Shalev AY, Bloch M, Peri T, et al. Alprazolam reduces response to loud tones in panic disorder but not in posttraumatic stress disorder. Biol Psychiatry. 1998;44:64-68.
27. Inder WJ, Prickett TC, Mulder RT, et al. Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology. 2001;156(1):73-78.
28. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Administration Booklet. Washington, DC: American Psychiatric Press; 1997.
29. Blake DD, Weathers FW, Nagy LM, et al. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-I. Behav Ther. 1990;13:187-188.
30. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety. 2001;13:132-156.
31. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
32. Connor KM, Davidson JRT. Further psychometric assessment of the TOP-8: a brief interview-based measure of PTSD. Depress Anxiety. 1999;9:135-137.
33. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41:209-218.
34. Weiss DS, Marmar CR. The Impact of Event Scale-Revised. In: Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. New York: Guilford; 1997:399-411.
35. Aardal E, Holm AC. Cortisol in saliva-reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem. 1995;33:927-932.
36. Riad-Fahmy D, Read GR, Walker RF, et al. Steroids in saliva for assessing endocrine functions. Endocr Rev. 1982;3:367-395.
37. Orr SP, Lasko NB, Metzger LJ, et al. Psychophysiologic assessment of women with posttraumatic stress disorder resulting from childhood sexual abuse. J Consult Clin Psychol. 1998;66(6):906-913.
38. Elzinga BM, Schmahl CG, Vermetten E, et al. Increased cortisol reactivity to trauma cues in posttraumatic stress disorder (PTSD). Poster presented at: Annual Meeting of the American Psychiatric Association; May 2002; Philadelphia PA.
39. Mason JW, Wang S, Yehuda R, et al. Marked lability in urinary cortisol levels in subgroups of combat veterans with posttraumatic stress disorder during an intensive exposure treatment program. Psychosom Med. 2002;64(2):238-246.
40. Shalev AY, Peri T, Brandes D, et al. Auditory startle response in trauma survivors with posttraumatic stress disorder: a prospective study. Am J Psychiatry. 2000;157(2):255-261.
41. Londberg PD, Hegel MT, Goldstein S, et al. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. J Clin Psychiatry. 2001;62:325-331.